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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYDefinitive hematopoietic stem cells (HSCs) develop in the aorta gonadmesonephros (AGM) region in a stepwisemanner. Type I pre-HSCs
express CD41 but lack CD45 expression, which is subsequently upregulated in type II pre-HSCs prior to their maturation into definitive
HSCs. Here, using ex vivo modeling of HSC development, we identify precursors of definitive HSCs in the trunk of the embryonic day
9.5 (E9.5) mouse embryo. These precursors, termed here pro-HSCs, are less mature than type I and II pre-HSCs. Although pro-HSCs
are CD41+, they lack the CD43 marker, which is gradually upregulated in the developing HSC lineage. We show that stem cell factor
(SCF), but not interleukin-3 (IL-3), is a major effector of HSCmaturation during E9–E10. This study extends further the previously estab-
lished hierarchical organization of the developing HSC lineage and presents it as a differentially regulated four-step process and identifies
additional targets that could facilitate the generation of transplantable HSCs from pluripotent cells for clinical needs.INTRODUCTION
The embryonic aorta gonad mesonephros (AGM) region is
an important site of hematopoietic stem cell (HSC) devel-
opment prior to colonization of the fetal liver (Dzierzak
and Speck, 2008;Medvinsky et al., 2011). At the embryonic
day 11 (E11) preliver stage, developing HSCs have also
been identified in the placenta, extraembryonic arteries,
and head (Dzierzak and Speck, 2008; Gekas et al., 2010;
Gordon-Keylock et al., 2013; Li et al., 2012). In the AGM re-
gion, definitive HSCs (dHSCs) are localized to the endothe-
lial lining of the dorsal aorta (de Bruijn et al., 2002; Rybtsov
et al., 2011). The first dHSCs emerging in the AGM region
express endothelial-specific markers such as vascular endo-
thelial cadherin (VE-cadherin) (Ivanovs et al., 2014; North
et al., 2002; Taoudi et al., 2005). Cell-fate experiments us-
ing permanent genetic labeling of embryonic endothelial
cells and their progeny provided strong evidence in favor
of the endothelial origin of HSCs (Chen et al., 2009; Zovein
et al., 2008). Live imaging in zebrafish revealed the forma-
tion of Runx1+ HSC/multipotent progenitors from the
endothelial lining of the dorsal aorta (Bertrand et al.,
2010; Kissa and Herbomel, 2010). Despite the strong indi-
cation that HSCs develop from a specialized hematogenic
endothelial lining of the dorsal aorta, it is becoming
increasingly apparent that this is not a single-step process
(Rybtsov et al., 2011; Taoudi et al., 2008). Furthermore,
some evidence suggests that divergence of the HSC lineage
from the embryonic endotheliummay occur prior to E10.5
before extensive formation of intra-aortic clusters (Rybtsov
et al., 2011; Swiers et al., 2013a; Yoder et al., 1997).Stem CellEx vivo modeling is a powerful tool for dissecting the
mechanisms of embryonic development of HSCs. During
a few days ex vivo, the AGM region and extraembryonic
arteries are capable of generating a large pool of dHSCs
comparable to that developing in the fetal liver (Gordon-
Keylock et al., 2013; Taoudi et al., 2008).While AGM region
explant cultures initially enabled HSC maturation to be
replicated in vitro (Medvinsky and Dzierzak, 1996), a disso-
ciation-reaggregation culture system thatwas subsequently
developed enabled analysis of individual cell populations
in the AGM region (Taoudi et al., 2008). Two types of em-
bryonic precursors sequentially developing into dHSCs
have been described in the E10.5–E11.5 AGM region:
type I pre-HSCs (VE-cad+CD45CD41lo) and type II pre-
HSCs (VE-cad+CD45+) (Rybtsov et al., 2011). Although
E11.5 dHSCs are localized to the endothelial layer of the
dorsal aorta (de Bruijn et al., 2002), type I and II pre-HSCs
are distributed more broadly both in the endothelial and
subendothelial cell layers (Rybtsov et al., 2011). At E11,
pre-HSCs have also been identified in extraembryonic ar-
teries (Gordon-Keylock et al., 2013). Meanwhile, cells of
the yolk sac cleanly severed from extraembryonic arteries
lack or show poor capacity to mature into dHSCs in similar
culture conditions (Gordon-Keylock et al., 2013; Rybtsov
et al., 2011).
Previous studies showed that the caudal part of the E8.5
embryo contains precursors that can give rise to low-level
repopulating hematopoietic cells (Cumano et al., 1996).
However, the development of true adult-type high-level re-
populating HSCs in culture has been achieved to date only
from E10.5 AGM region cells (Robin et al., 2006; RybtsovReports j Vol. 3 j 489–501 j September 9, 2014 j ª2014 The Authors 489
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the mechanics of HSC development requires tracking and
characterization of the entire embryonic pathway leading
to dHSC formation, covering earlier stages of development.
Here, we aimed to characterize the cell type immediately
preceding the emergence of type I pre-HSCs by focusing
on the E9.5 stage. We have been able to mature dHSCs
from the E9.5 caudal part of the embryo body. As expected,
the maturation of these early precursors into dHSCs re-
quires a longer time than of E11.5 AGM region-derived
type I and II pre-HSCs.
Embryonic precursors of dHSCs are known to express
CD41 (Bertrand et al., 2005; Ferkowicz et al., 2003;
McKinney-Freeman et al., 2009; Rybtsov et al., 2011). We
show that E9.5 HSC precursors also express CD41 and
RUNX1 but in contrast to later (including adult) stages
lack expression of CD43 (Moore et al., 1994). E9.5 HSC pre-
cursors and type I pre-HSCs can mature into dHSCs in
response to stem cell factor (SCF), but not interleukin-3
(IL3), although for type II pre-HSCs, SCF and IL-3 are
equally active. Such strong early dependency on SCF, but
not IL-3, identifies SCF as a major HSC maturation factor,
which is consistent with the dramatic HSC deficiency in
SCF knockouts, but not in IL-3 knockouts (Ding et al.,
2012). Taken together, these features identify the E9.5 pre-
cursor as a distinct hematopoietically committed cell type
termed here ‘‘pro-HSC.’’
In summary, using a modified ex vivo protocol enabling
replication of HSC development from the E9.5 mouse
embryo, we characterize here an early hematopoietic
precursor in the HSC hierarchy (pro-HSC) localized to the
aortic region of the E9.5 embryo. Pro-HSCs are VE-
cad+CD45CD41loCD43 and SCF dependent and precede
the appearance of type I pre-HSCs in the AGM region.
Taken together with previous studies, HSC development
between E9.5 and E11.5 can be characterized as a four-
step process driven primarily by SCF.RESULTS
E9.5 Precursors Require a Longer Time than Type I and
II Pre-HSCs to Mature into dHSCs
Previous studies showed that 3–4 days in culture is suffi-
cient for dHSCs maturation from E11.5 AGM cells (Med-
vinsky and Dzierzak, 1996; Taoudi et al., 2008). Our
attempts to obtain dHSCs by culturing the caudal part
of E9.5 embryo using similar conditions have failed, and
we reasoned that precursors of HSCs from this early stage
may require a longer culture period. Therefore, cell sus-
pensions obtained from caudal parts of E9.5 embryos
were coaggregated with OP9 cells and cultured for
7 days on floating membranes at the gas-liquid interphase490 Stem Cell Reports j Vol. 3 j 489–501 j September 9, 2014 j ª2014 The Ain presence of three growth factors (termed further
3GF): IL-3, SCF, and Fms-related tyrosine kinase 3 ligand
(FLT3L). After 7 days in culture, cells were transplanted
intravenously into adult irradiated recipients, which
resulted in a long-term multilineage high-level hema-
topoietic repopulation (Figure 1A). Systematic analysis
demonstrated a significant gap in maturation kinetics be-
tween HSC precursors in E9.5 and E10.5/E11.5 embryos.
While late E10.5 and E11.5 pre-HSCs can mature into
dHSCs during 4 days culture, E9.5 precursors produce
dHSC only after 7 days of culture (Figure 1A; Taoudi
et al., 2008), and coaggregation with OP9 cells facilitated
dHSCs maturation from E9.5 cells (Figure S1A available
online). Primary and secondary transplantations of bone
marrow from primary recipients repopulated with E9.5-
derived cells showed balanced long-term multilineage
engraftment detectable in the peripheral blood and
lymphohematopoietic organs (Figures S1B–S1E) (Muller-
Sieburg et al., 2012).
Pro-HSCs Are Distributed along the Aortic Region
between the Heart and the Base of the Umbilical Cord
To investigate the localization of pro-HSCs in the E9.5 em-
bryo, cell suspensions obtained from the E9.5 caudal part
(trunk below heart level), anterior part (AP; including the
rest of the body), yolk sac, and placenta were coaggregated
with OP9 cells, cultured for 7 days with 3GF, and then
transplanted into irradiated recipients (Figure 1B). Only
the caudal part was able to generate dHSCs. None of other
tissues, including those that harbor HSCs at later stages
(placenta, yolk sac, and anterior part above the heart,
including the head), contained precursors capable of
maturing into dHSCs. Of note, the caudal part generates
HSCs regardless of low content of colony-forming units
in culture (CFU-C), whereas the yolk sac lacks HSC poten-
tial, despite the presence of large numbers of CFU-C (Fig-
ures 1B and 1C).
To determine more accurately the localization of pro-
HSCs, E9.5 caudal parts were sectioned into thick trans-
verse slices along the longitudinal axis (Figure 1D) that
were tested for their ability to generate dHSCs. The
following subregions were tested: umbilical cord (a), tail
(b), posterior caudal part (one-third of the caudal part
excluding tail harboring the region of 5 somite pairs
(sp) around the base of the umbilical cord) (c); intermediate
caudal part (intermediate one-third of the caudal part 5
sp) (d); rostral caudal part (one-third of the caudal part adja-
cent to the heart, including the base of the vitelline vein,
but not the vitelline artery) (e); and anterior part including
the heart, neck, and head (AP). We found that all trunk sec-
tions (except umbilical cord and tip of tail) below the heart
level were able to generate dHSCs following 7-day coaggre-
gation culture (Figure 1E).uthors
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Figure 1. Pro-HSC Maturation into dHSCs
(A) While dHSCs from E10.5 precursors appeared after 4 days in culture (green diamonds), E9.5 caudal part precursors matured into dHSCs
only by day 7 in culture (red diamonds) (two independent experiments).
(B) Pro-HSCs are localized to the caudal part of the embryo body, but not in other intra- or extraembryonic tissues (three independent
experiments).
(C) The yolk sac, but not the caudal part, contains large numbers of CFU-C (comparisons between yolk sac and caudal parts of individually
staged embryos are shown; two independent experiments).
(D) Dissection strategy for E9.5 embryo (24 sp): a, umbilical cord; b, tip of the tail; c, posteriormost one-third of the caudal part excluding
the tail tip; d, intermediate one-third of the caudal part; and e, rostralmost one-third of the caudal part immediately below the heart level;
anterior part (AP) including the heart, neck, and head.
(E) Subdissected regions from individual embryos were separately cocultured with OP9 cells. Presence of pro-HSCs in different regions
(x axis) and level of donor-derived engraftment (y axis) is indicated. Age of individual embryos (24–28 sp) is indicated (z axis). Each color
depicts one embryo (four independent experiments).
(F) Pro-HSCs stably emerge in the embryonic caudal part from 24 sp stage. On rare occasions, dHSCs developed in embryos between 15 and
23 sp (three independent experiments).
Diamond symbols represent individual recipients. Number of e.e. transplanted per recipient (ee/rec) is shown. Dissection scheme shown
on CD41Cre::sGFP embryo for better orientation (Rybtsov et al., 2011). For multilineage analyses, see Figure S1. Each plot represents two to
four independent experiments.
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Figure 2. Stepwise Phenotypic Progression of the HSC Lineage during E9.5 to E11.5
(A) Sorting strategies for the developing HSC lineage (plots show 7AADLin cells).
(B) Functional identification of members of the developing HSC hierarchy. Sorting strategy (see also Figure S2) and functional vali-
dation for:
(a and a0) E9 VC+CD45: repopulation achieved with R2 cells (note that the VC-negative population was also tested and gave no
repopulation), four independent experiments;
(b and b0) E10 VC+CD45: repopulation achieved with R2 and R3 cells, two independent experiments;
(c and c0) E11 VC+CD45: repopulation achieved only with R1 cells, three independent experiments;
(d and d0) E11 VC+CD45+: repopulation achieved only with R2 cells, three independent experiments;
(legend continued on next page)
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Pro-HSCs: Earliest Members of the HSC LineageEffective Emergence of Pro-HSCs Occurs from 23/
24 Sp Stage
To determine the exact stage at which pro-HSCs appear,
embryos were grouped in accordance with their age (sp)
and coaggregated with OP9 cells. A few embryos in E9.5
litters were found to be retarded and had only 15–17 sp,
normally detected in E8.5 litters. Each adult recipient was
transplanted with 2–1–2 e.e. (embryo equivalents) of
cultured cells from each stage. Although on rare occasions,
embryos from 15–17 sp to 23 sp were able to generate
dHSCs, only 24 sp and older embryos showed consistent
presence of pro-HSCs (Figure 1F). Indeed, only 5 out of 33
recipients of younger than 24 sp caudal parts showed he-
matopoietic repopulation (of total 66 e.e. transplanted),
whereas 26 of 30 recipients transplanted with cultured
24–29 sp caudal parts (in total 30 e.e.) achieved high-level
long-term hematopoietic engraftment.
Pro-HSCs are CD41+CD43 and Upregulate CD43
during HSC Lineage Development
To identify the phenotype of pro-HSCs, the Lin-VC+CD45
population isolated from the E9.5 (24–29 sp) caudal part
was sorted into four fractions based on CD41 and CD43
staining. After coaggregation with OP9 cells and 7-day cul-
ture, cells were transplanted into irradiated recipients (Fig-
ure S2A). Only the VC+CD45CD41loCD43 fraction gave
rise to dHSCs (Figures 2Aa and 2Ba0). By the beginning of
E10 (30–34 sp), not only the CD41+CD43 but also the
CD41+CD43+ subsets within the VC+CD45 population
were capable of maturing into dHSCs (Figures 2Ab and
2Bb0). By E11.5, both type I and type II pre-HSCs were
exclusively CD43+ (Figures 2Ac, 2Bc0, 2Ad, and 2Bd0,
respectively). Of note, CD43 expression increases during
transition from type I pre-HSCs into type II pre-HSCs and
upregulates further in adult bone marrow HSCs (Figures
S2B and S2C). Of note, E11.5 VC+CD43+ populations en-
riched for both types of pre-HSCs are very efficient at gener-
ating CFU-C (Figure 2H).
We thenmonitored phenotypic progression of pro-HSCs
maturing ex vivo. Stepwise transition of pro-HSCs
(VC+CD45CD41loCD43Lin) into the CD45CD43+
(type I pre-HSCs) phenotype and subsequently into the(C and D) Tracking CD43 and CD45 upregulation in cultured pro-HSCs. S
E9 caudal parts (C, left). Sorting purity of this population (C, right)
upregulation of CD43 in cultured during 7 days ex vivo (note that CD
experiments).
(E and F) By the end of culture, E9 caudal parts produce definitiv
demonstrated by transplantation of sorted live cells (F) (two indepen
(G) Demonstration of coexpression of CD41 and RUNX1 in E9 live VC+C
(H) CFU-C potential of sorted E11 populations. (a) CFU-C are generat
experiments). Error bars represent SD. (b) CFU-C are generated predo
ments). Error bars represent SD.
Stem CellCD45+CD43+ (dHSCs) phenotype could be followed over
time in culture (Figures 2C and 2D). The CD45+CD43+
phenotype of dHSCs emerging in culture was further
confirmed by the functional transplantation analysis (Fig-
ures 2E and 2F).
Pro-HSCs Are Present in the Dorsal Aorta, but Not in
Other Large Vessels
In E9.5 embryos, the VC+CD45CD41+ population en-
riched for pro-HSCs coexpresses RUNX1, as shown by
intracellular antibody staining (Figure 2G). The E9.5 VC+
aortic lining almost completely lacks CD43 expression
but shows RUNX1 expression (predominantly in its ventral
domain), suggesting the presence of pro-HSCs in this loca-
tion (Figures 3A and 3A0, yellow arrow). Small vessels
branching from the ventral domain of the aorta also
contain individual VC+CD43RUNX1+ cells (Figures 3A0
and 3B, yellow arrowheads). In contrast, the omphalome-
senteric (OA) and vitelline and umbilical arteries (UA)
contain strings of large prominent clusters composed of
VC+CD43+RUNX1+ cells (Figures 3B, 3B0, and S3A–S3C).
Rare VCCD43+RUNX1+ cells can also be detected in the
E9.5 circulation (Figure S3D).
Cell clusters emerge inthedorsal aortaonlybyE10contain
mainly VC+CD43+CD45 cells and some VC+CD43+CD45+
cells (Figures 3C and 3D). Some cells in clusters also coex-
press RUNX1 (Figure 3 E). Similar to intra-aortic clusters,
intra-UA and intra-OA clusters by E10–E10.5 are mainly
composed of CD43+ cells, some of which start upregulating
CD45 (Figures S3A–S3C). Most of the CD45+ cells scattered
in the embryo body lack CD43 expression and are likely to
be mature macrophages (Figures 3C and 3D).
To more precisely determine the location of pro-HSCs,
we subdissected the E9.5 caudal part (Figures 3F and 3G).
After separation of the yolk sac, somites, and lateral
body walls (‘‘ribs’’), we isolated and cultured the OA, the
UA, the vitelline vein with surrounding mesenchyme
(including liver rudiment), and the dorsal aorta. We found
that dHSCs predominantly developed from the aortic re-
gion, which has smooth endothelial lining, and practically
none were generated by the OA (Figure 3H), despite the
presence of large CD43+ clusters.orting strategy of pro-HSCs (LinVC+CD41loCD43CD45) from fresh
. Pure, sorted, LinVC+ CD41loCD43CD45 pro-HSCs show gradual
45 upregulation occurs with a slight delay) (D) (two independent
e HSCs with the CD43+CD45+ phenotype (E) (located in R1), as
dent experiments).
D45 population shown by intracellular RUNX1 antibody staining.
ed predominantly by R1 cells sorted as in (Ac) (three independent
minantly by R2 cells sorted as in (Ad) (three independent experi-
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Distinguishable by CD43 and cKIT Expression Levels
The above experiments determined that pro-HSCs reside
within the VC+CD45CD41+CD43 population. To test
whether CFU-C also reside in this fraction, VC+CD45 pop-
ulations were sorted from the E9.5 caudal parts on the basis
of CD41 and CD43 staining and plated in a methylcellu-
lose assay (Figure 4A). The absolute majority of CFU-C
(20CFU-C/e.e.) were detected in theCD41+CD43+ fraction,
whereas the CD41+CD43 population, which is enriched
for pro-HSCs, contained only 1 CFU-C/e.e. (Figure 4B).
This suggests that CFU-C are localized mainly to UA and
OA. To test this, we dissected and separately examined
the dorsal aorta and UA + OA in the methylcellulose assay
and found approximately 2- to 5-fold more CFU-C in UA +
OA than in the dorsal aorta (depending on the exact age of
the embryo) (Figure 3I). These data suggest that large
CD41+CD43+ clusters within the OA and UA are the sour-
ces of CFU-C.
We then investigated cKIT (SCF receptor) expression on
CFU-C and found that the entire VC+CD45CD41+CD43+
population expresses cKIT at a high level. Meanwhile, the
VC+CD45CD41loCD43 population enriched for pro-
HSCs express cKIT at lower levels (Figure 4C). Thus, pro-
HSCs and CFU-C are phenotypically distinct and tend to
be spatially segregated in the embryo.
Pro-HSCs Are Devoid of Endothelial Potential
We have previously shown that type I and II pre-HSCs do
not produce endothelial colonies in the clonogenic endo-
thelial assay (Rybtsov et al., 2011; Taoudi et al., 2005). As
expected, the main endothelial potential in E9.5 embryosFigure 3. Phenotypic Mapping of Pro-HSC Localization
(A) VC+CD43+RUNX1+ cells localize to the ventral floor of the E9 dor
indicate cells with pro-HSC phenotype. Red arrows show RUNX1+VC+ p
(B) Hematopoietic development in the E9 omphalomesenteric artery (
VC+CD43+RUNX1+ clusters. Note the presence of VC+CD43RUNX1+cel
heads). Zoomed image of the boxed area is shown in (B0). Yellow arrow
cells.
(C) Small ventrally located intra-aortic clusters appearing at E10 con
(D) E10 rare VC+CD43+ cells in small intra-aortic clusters show expressio
contains large clusters of VE-cad+CD45CD43+ (blue arrow) not assoc
(E) E10 intra-aortic clusters are VE-cad+CD43+RUNX1+.
(F) Fine spatial localization of pro-HSCs in the caudal part of the body
UA as indicated schematically by double dotted line in (G) (green dot
red color. Violet color depicts vitelline veins (VV).
(H) Dorsal aorta is the main site of pro-HSC residence. Dissected subr
with OP9 cells and transplanted into irradiated recipients.
(I) CFU-C contents in UA + OA and DA. UA + OA contains significantly m
of individually staged embryos are shown).
Abbreviations: OA, omphalomesenteric artery; DA, dorsal aorta; UA, um
somites; Hrt, heart. Crossed double-headed arrows indicate dorsoven
arrow indicates the lumen of dorsal aorta (DA). Each plot represents
Stem Cellis associated with the VC+CD45CD41CD43 population
as shown by clonogenic endothelial assays where approxi-
mately 100 endothelial colonies (CFU-C_En) were detected
per 1 e.e. (Figure 4B). Even though 6 e.e. were taken for each
experiment, the VC+CD45CD41+CD43+ populations en-
riched for CFU-C produced no CFU-C_En. We then tested
the endothelial potential of pro-HSCs (VC+CD45CD41+
CD43) and found that this population produces very
few endothelial colonies (10 CFU-C_En/e.e.) represented
mainly by single tubules that were spatially segregated
from rare CFU-C hematopoietic colonies (Figure 4B).
SCF Alone Is Sufficient to Induce Maturation of
Pro-HSCs and Type I Pre-HSCs into dHSCs
Previous studies showed that IL-3, on its own or in combi-
nation with other factors (SCF and FLT3L), is capable of
inducing maturation of dHSCs from the E10.5–E11.5
AGM region (Robin et al., 2006; Taoudi et al., 2008). We
have shown above that 3GF combination is also effective
for induction of E9.5 pro-HSCs (Figures 1A–1C.) and
further tested which of these factors are essential for this
process. In contrast to Il3, Scf is expressed at a substantial
level in the E9.5 dorsal aorta and increases 2.5-fold by
E10.5 (Figure 5C). Given the expression of cKIT in pro-
HSCs (Figure 4C) and the increase in Scf expression in vivo
(Figure 5C), we tested whether SCF can induce maturation
of pro-HSCs in vitro. Indeed, the addition of soluble SCF
induced efficient production of dHSCs (in seven out of
nine recipients repopulated) with high engraftment capac-
ity (range of blood chimerism, 45%–84%) (Figure 5A).
In contrast, the effect of IL-3 was much weaker. Only 3 of
11 recipients transplanted with IL-3-treated cultures ofsal aorta. Zoomed boxed area is shown in (A0). Yellow arrowheads
ro-HSCs localized to the ventral endothelium.
OA). The OA, but not the dorsal aorta (DA), contains strings of large
ls in small vessels connecting OA and DA (shown by yellow arrow-
indicates a large cluster inside the OA composed of VC+CD43+RUNX1+
tain cells expressing CD43, but not CD45.
n of CD45 (yellow arrow). Subendothelial (aortic) mesenchyme (SM)
iated with vessels.
. Dissection strategy shown on a thick transverse slice in the area of
ted line indicates subdissections). DA, OA, and UA are indicated by
egions of E9.5 caudal part (as shown in (F) and (G) were cocultured
ore CFU-C than dorsal aorta (comparisons between UA + OA and DA
bilical artery; VV, vitelline vein; SCM, subcardiac mesenchyme; Som,
tral (D-V) and posterior-arterial (P-A) orientations. Double-headed
two independent experiments.
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Figure 4. CFU-C in the E9.5 Embryo Are
Marked by High cKIT and CD43 Expression
(A) Gating strategy for identification of CFU-
C and endothelial progenitors in E9.5 caudal
part; live LinVC+CD45 cells were sorted on
the basis of CD41 and CD43 expression.
(B) Four sorted populations (as indicated
in A) were tested for hematopoietic CFU-C
and endothelial progenitors CFU-En (fre-
quencies per e.e. are shown). While CFU-C
resided in R2 (note the large numbers of
multilineage colonies, CFU-GEMM gener-
ated), CFU-En resided in R4. Error bars
represent SD.
(C) CFU-C population (R2) shows high level of cKIT expression, whereas pro-HSCs (R3) express cKIT at intermediate levels (cKIT expression
and control FMO are depicted by blue and red colors, respectively). Each plot represents two independent experiments.
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ment at relatively modest levels (7%–25% blood chime-
rism) (Figure 5A). Incubation with SCF and IL-3 together
showed a moderate potentiating effect (13 out of 13 recip-
ients with 8%–86% donor-derived engraftment in blood)
(Figures 5A and 5D). FLT3L on its own showed little or prac-
tically no effect and in combination with SCF or/and IL-3
only slightly improved engraftment, if at all (data not
shown). Of note, combined incubation with SCF and IL-3
tends to increase myeloid donor-derived contribution
(Figure 5D).
We then tested whether the next stage (type I pre-HSCs)
retains the predominant responsiveness to SCF. Sorted
E11.5 AGM type I pre-HSCs were cocultured with OP9 cells
in the presence of either SCF or IL-3.While cultures supple-
mented with exogenous SCF repopulated seven out of
eight recipients (three low and four high) (Figure 5B, left),
cultures supplemented with IL-3 gave repopulation in
only one of seven recipients. Again, SCF and IL-3 in combi-
nation showed a potentiating effect on dHSC development
(Figures 5A and 5B).
We then tested effects of IL-3 and SCF on type II pre-HSCs
isolated from the E11.5 AGM region and coaggregated with
OP9 cells. Control cultures (no exogenous growth factors)
generated a few dHSCs resulting in repopulation of four
out of seven recipients with modest engraftment levels
(3%–27%) (Figure 5B, right). However, addition of exoge-
nous SCF resulted in engraftment of all six recipient mice
with high-level donor-derived chimerism (10%–54%). In
line with previous reports, incubation with IL-3 was also
effective, with seven out of eight recipients being repopu-
lated at various levels (Figure 5B, right). Culturing with
SCF and IL-3 together showed no improvement over the in-
dividual effects of IL-3 or SCF (Figure 5B). Thus, pro-HSCs
and type I pre-HSCs show strong responsiveness to SCF,
whereas type II pre-HSCs can mature equally well in
response to SCF or IL-3 alone.496 Stem Cell Reports j Vol. 3 j 489–501 j September 9, 2014 j ª2014 The ADISCUSSION
Although the first hematopoietic differentiation occurs in
the yolk sac of the E7.5 mouse embryo, definitive HSCs
giving rise to the entire adult hematopoietic system
emerge only by late E10.5–E11.0 (Dzierzak and Speck,
2008; Medvinsky et al., 2011; Swiers et al., 2013b). There
is a strong line of evidence to suggest an endothelial
origin for the adult hematopoietic hierarchy (Bertrand
et al., 2010; Chen et al., 2009; de Bruijn et al., 2002; Kissa
and Herbomel, 2010; Zovein et al., 2008). From early
developmental stages, the HSC lineage shares VE-cadherin
expression with endothelial cells, which is subsequently
downregulated during fetal life (Kim et al., 2005; Taoudi
et al., 2005). Hematopoietic progenitors (CFU-C) in the
early embryo express CD41 and only later become
CD45+ (Mikkola et al., 2003). The HSC lineage evolves
rapidly through sequential developmental stages marked
by upregulation of CD41 (type I pre-HSCs: VC+CD41lo
CD45) followed by upregulation of CD45 in type II
pre-HSCs (VC+CD45+) before becoming competent
dHSCs (Rybtsov et al., 2011; Taoudi et al., 2008). The anal-
ysis of earlier precursors of HSCs has to date been
hampered by the lack of an adequate in vitro system
that would support HSC development from very early
developmental stages.
Here, we developed an in vitro system which allowed us
to characterize E9.5 dHSCs precursors, termed here pro-
HSCs, preceding the appearance of type I pre-HSCs in
E10.5 embryos (Rybtsov et al., 2011). Pro-HSCs differ
from subsequent stages by two important characteristics:
(1) in agreement with a more immature status, pro-HSCs
require a longer culture period (7 days) to mature into
dHSCs compared to pre-HSCs; and (2) pro-HSCs are
VC+CD41+RUNX1+CD45 but lack expression of the
CD43 marker, which is upregulated at later stages begin-
ning from type I pre-HSCs.uthors
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Figure 5. Growth Factor Requirements
for Pro-/Pre-HSC Development
(A) E9 pro-HSCs mature into dHSCs in
presence of SCF (S), but not IL-3 (I) (1
e.e./recipient; four independent experi-
ments).
(B) E11 type I pre-HSCs respond by maturing
into dHSCs in the presence of SCF, but not
IL-3. Meanwhile, type II pre-HSCs respond
equally well to SCF and IL-3 (left and right,
respectively). Transplantations: type I pre-
HSCs: 0.2 ee/recipient (left) and type II
pre-HSCs: 0.3 ee/recipient (right) (three
independent experiments).
(C) Scf expression in the dorsal aorta, as
measured by quantitative PCR, increases
2.5-fold between E9.5 and E10.5. Note that
cKit expression remains at the same level
during this period of time. Expression levels
are normalized to Tbp housekeeping gene expression (three independent RNA preparations). Error bars represent SD.
(D) Long-term donor-derived lymphoid and myeloid contribution in recipient blood derived from E9.5 caudal parts. While SCF on its own
generates dHSCs with balanced lymphomyeloid differentiation (15%–20% of lymphoid cells), IL-3 on its own or in combination with SCF
tends to shift balance more toward myeloid differentiation. Each bar represents an individual recipient (two independent experiments).
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Pro-HSCs: Earliest Members of the HSC LineageHSC development is regulated by various transcription
factors and signaling pathways (Bigas et al., 2013; Chanda
et al., 2013; Chen et al., 2009; Guiu et al., 2013; Leung
et al., 2013; Nimmo et al., 2013; Richard et al., 2013). Previ-
ous studies showed that IL-3 is a potent inducer of dHSC
maturation in the E10.5–11.5 AGM region (Robin et al.,
2006); however, we demonstrate that IL-3 has very little ef-
fect on pro-HSCs. By contrast, SCF has a strong maturation
effect on pro-HSCs. Furthermore, SCF is a strong trigger of
dHSC maturation from both type I and type II pre-HSCs.
Scf is clearly expressed in the E9.5 aorta and is significantly
upregulated by E10.5, thus correlating with pro-HSC to pre-
HSC transition. Of note, weak and inconsistent Il3 expres-
sion becomes detectable only in the E11.5 dorsal aorta in
parallel with the emergence of type II pre-HSCs (Gordon-
Keylock et al., 2013). These findings indicate that SCF is
themajor early factor initiatingHSCdevelopment, in agree-
ment with a critical decline in HSC activity in SCFmutants,
which die perinatally (Ding et al., 2012), while IL3 knock-
outs remain viable into adulthood (Lantz et al., 1998; Robin
et al., 2006). Concurrent SCF and IL-3 actionhas only an ad-
ditive or weakly potentiating effect on pro-HSC/pre-HSC
maturation, and a similar interaction between SCF and
IL-3 has been described in mast cells (Dvorak et al., 1994).
The HSC lineage and CFU-C develop in parallel in the
embryo, and their exact relationship is poorly understood
(Medvinsky et al., 2011). Some data indicate that they
emerge from distinct endothelial compartments (Chen
et al., 2011). However, the analysis of mechanistic differ-
ences between these two cell types is hampered by our
inability to reliably distinguish developing HSCs andStem CellCFU-C by phenotype. Here, we show that CD43 marker
clearly segregates these populations in the E9.5 embryo as
pro-HSCs, in contrast to CFU-C, do not express CD43. In
addition, pro-HSCs express cKIT at significantly lower
levels than E9.5 CFU-C. Low cKITexpression is also charac-
teristic of quiescent adult bone marrow HSCs (Grinenko
et al., 2014; Matsuoka et al., 2011; Shin et al., 2014).
Confocal analysis showed that CD43+ cells reside mainly
within large cell clusters in the OA, but not in the dorsal
aorta, suggesting association of CFU-C activity with intra-
OA clusters. The VE-cad+CD43RUNX1+ population,
which is enriched for pro-HSCs, is localized to the ventral
endothelial lining of the dorsal aorta and small vessels
branching from the aorta.
Subdissection of E9.5 caudal parts followed by functional
analysis confirmed that pro-HSCs are closely associated
with the dorsal aorta and could be found at different levels
between the heart and the base of the umbilical cord. Thus,
pro-HSCs develop prior to formation of intra-aortic clus-
ters. Contrary to a previous supposition (Zovein et al.,
2010), strings of large VC+CD43+RUNX1+ clusters inside
OA and in extraembryonic vessels at E9.5 are not enriched
for pro-HSCs. Only later do extraembryonic vessels develop
pre-HSCs in fairly low numbers (Gordon-Keylock et al.,
2013). Pre-HSCs can be also found at later stages in suben-
dothelial layers of the dorsal aorta (Rybtsov et al., 2011).
The majority of cells with pro-HSC phenotype (E9.5) are
localized to the endothelium of the dorsal aorta and we
confirmed their nature functionally. However, similar rare
cells can be found at E9.5 both in subaortic capillaries
and in larger vitelline/umbilical arteries. It needs to beReports j Vol. 3 j 489–501 j September 9, 2014 j ª2014 The Authors 497
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Figure 6. Schematic Development of the HSC Lineage in the
Context of Growth Factor—SCF and IL-3—Dependency
Proposed stepwise development of the HSC lineage in the dorsal
aorta beginning from E9.5 stage based on cumulative data obtained
from current research and previous publications (Rybtsov et al.,
2011; Taoudi et al., 2008). Color coding shows a transient increase
in CD41 expression at E9.5 followed by stable gradual upregulation
of CD43 and subsequent elevation of CD45 expression. Modulation
of VE-cadherin, cKIT, and RUNX1 expression was not studied in
detail, and these are presented schematically at steady levels
throughout E9–E11 stages. Stage-specific dependency on SCF and
IL-3 is indicated within arrows showing transition of one stage to
another. Abbreviations: HE, hematogenic endothelium; Pro, pro-
HSC; pre- I, type I pre-HSCs; pre- II, type II pre-HSCs; HSC, defin-
itive HSCs. Images of cells were downloaded from Servier Medical
Art (http://www.servier.com/) with the owner’s permission.
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Pro-HSCs: Earliest Members of the HSC Lineageelucidated further whether pre-HSCs in these sites develop
locally with delay or are colonized later by pre-HSCs from
the dorsal aorta.
CD43 expression allows clear morphological tracking of
intra-aortic cluster formation in E10.5 embryos. During
HSC lineage development, CD43 is progressively upregu-
lated, reaching high expression levels by E11.5 in pre-
type II HSCs. Whether CD43, known to have antiadherent
function (Drew et al., 2005), is involved in release of dHSCs
from the AGM region niche prior to colonization of the
fetal liver needs to be elucidated in future. In the adult
CD43 is implicated in transendothelial migration of T-lym-
phocytes and possibly HSCs through interaction with E-se-
lectin (Manjunath et al., 1995; Winkler et al., 2012;
Woodman et al., 1998).
The prevailing dogma in the field describes emergence of
HSCsdirectly fromhematogenic endothelium.All described
precursors of the HSC lineage express VE-cadherin. Howev-
er, while pro-HSCs are hematopoietically committed
(CD41+RUNX1+) and readily generate hematopoietic col-
onies, they lack endothelial potential. It has recently been
proposed that the hematogenic endothelium expresses
only Runx1 mRNA, but not the protein (Swiers et al.,
2013a); however, pro-HSCs express RUNX1 at the protein
level. Taken together, this places pro-HSCs in an advanced
developmental position and indicates that they have
already segregated from the hematogenic endothelium.498 Stem Cell Reports j Vol. 3 j 489–501 j September 9, 2014 j ª2014 The ABased on the level of immaturity, surface immunophe-
notype and responsiveness to SCF/IL-3, E9.5 precursors
identified here are termed pro-HSCs. Based on this under-
standing, we propose a model that includes four consecu-
tive stages of HSC development (Figure 6).
In summary, this study highlights extended hierarchical
organization of the developingHSC lineage.We identify an
E9.5 pro-HSC as an upstream precursor distinct from subse-
quent members of the developing HSC lineage based on
CD43 phenotype, dependence on SCF, but not on IL-3,
and the extended time required for maturation into dHSCs
in culture. We show that SCF is a major effector of HSC
maturation during E9–E10. Interestingly, soluble SCF has
a dramatic enhancing effect on maturation of HSCs,
althoughOP9 cells express high levels ofmembrane-bound
SCF. This study defines both a key cellular intermediate and
appropriate culture conditions thatmay improve protocols
for generating transplantable HSCs from pluripotent cells
for clinical needs, which remains a challenge in the field.
Further studies will need to elucidate molecular mecha-
nisms underlying stepwise HSC development.EXPERIMENTAL PROCEDURES
Animals
Staged embryos were obtained by mating C57BL/6 (CD45.2/2) or
C57BL/6 enhanced GFP mice. The morning of discovery of the
vaginal plugwas designated as day 0.5.More accurate embryo stag-
ing was performed by counting somite pairs (sp) and grouped as
E9.0 (15–24 sp), E9.5 (25–29 sp), E10.0 (31–34 sp), E10.5 (35–39
sp), and E11.0–E11.5 (>40 sp). All experiments with animals
were performed under Project License granted by the Home Office
(UK), University of Edinburgh Ethical Review Committee, and
conducted in accordance with local guidelines.
Long-Term Repopulation Assay
CD45.2/2 (or GFP+) cells were injected into adult irradiated
CD45.1/2 heterozygous recipients along with 100,000 CD45.1/1
nucleated bone marrow carrier cells per recipient. Recipients were
Ɣ-irradiated by split dose (600 + 550 rad) with a 3 hr interval.
Numbers of cells injected are expressed in embryo equivalents
(e.e.), where 1 e.e. corresponds to a cell population sorted from
one embryo after adjustment for dead cells. Percentage donor-
derived chimerism was evaluated in peripheral blood at 6.5 weeks,
14 weeks, and 12 months posttransplantation using FACSCalibur
or Fortessa (BD Biosciences). Erythrocytes were depleted using
PharM Lyse (BD Bioscience), and cells were stained with anti-
CD16/32 (Fc-block) followed by anti-CD45.1-APC (cloneA20) and
anti-CD45.2-PE (clone 104) monoclonal antibodies (eBioscience).
HSC numbers were assessed using ELDA analysis (Hu and Smyth,
2009). Multilineage donor-derived hematopoietic contribution in
recipient blood and organs was determined by staining with anti-
CD45.1-V450, anti-CD45.2-V500 and lineage-specific anti-Mac1
fluorescein isothiocyanate (FITC), Gr1-PE CD3e-APC, B220-PE-
Cy7 monoclonal antibodies (BD Pharmingen).uthors
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Fine needles suitable for microdissection of E9 embryos were pre-
pared by electrolysis of tungsten wire in 2 M NaOH with one or
two drops of Decon 60 (Ekvall et al., 1999), using an engineered
automated programmable machine built in-house. Embryo isola-
tion and dissection were performed in Dulbecco’s PBS (+Ca+Mg)
(GIBCO) supplemented with 7% heat-inactivated fetal bovine
serum (FBS) (PAA Laboratories), 100 U/ml penicillin (Life Technol-
ogies), and 100 mg/ml streptomycin (Life Technologies). Tissues
were incubated with collagenase/dispase (1 mg/ml collagenase/
dispase, Roche) at 37 and washed with fluorescence-activated
cell sorting (FACS) buffer (Ca2+ and Mg2+-free PBS, Sigma) supple-
mentedwith 5% FBS and dissociated in FACS buffer. Yolk sacs were
carefully separated from the vitelline/omphalomesenteric arteries
and umbilical cords.
HSC Ex Vivo Maturation
Cells from E9.5 caudal parts dissociated by collagenase/dispase
were sorted and either reaggregated or coaggregatedwithOP9 cells.
To this end, cell suspension containing 1 e.e. caudal part or sorted
cells and 105 OP9 cells in 30 ml volume of media (Iscove’s modified
Dulbecco’s medium [IMDM], Invitrogen-GIBCO, 20% of prese-
lected, heat-inactivated FBS, PAA Laboratories, L-glutamine, peni-
cillin/streptomycin) were centrifuged at 450 3 g/12 min in
200 ml pipette tips sealed with parafilm (Taoudi et al., 2008).
When appropriate, the IMDM was supplemented with murine re-
combinant cytokines in concentration 100 ng/ml (all from Pepro-
Tech). Coaggregates were cultured on floating 0.8 mm AAWP
25 mm nitrocellulose membranes (Millipore) for 24 hr followed
by complete replacement of medium followed by additional
4–6 days culture. E11.5 pre-HSCs were assayed as previously
described (Rybtsov et al., 2011). Cultured aggregates were dissoci-
ated using collagenase/dispase. All experiments were performed
at least twice independently.
CFU-C and Endothelial Assays
Dissociated cells were plated in methylcellulose culture (Metho-
Cult3434 medium; STEMCELL Technologies) according to the
manufacturer’s instructions. For endothelial hematopoietic clono-
genic assays, we used an OP9-based assay (Taoudi et al., 2005).
Briefly, a cell population was plated on OP9 cells in the methylcel-
lulose medium supplemented with 100 ng/ml SCF and 50 ng/ml
vascular endothelial growth factor (PeproTech). After 11 days, cul-
tures were stained with anti-CD31 antibodies to assess formation
of hematopoietic and endothelial colonies.
Fluorescence-Activated Cell Sorting and Analysis
The following antibodies were used: anti-CD41-BV421 (brilliant
violet 421) or Alexa Fluor 488 (clone MW30reg) anti-CD45 FITC
(clone 30-F11), anti-CD43-PE (clone eBioR2/60), and biotinylated
anti-VE-cadherin (clone 11.D4.1) followed by incubation with
streptavidin-APC (all purchased from BD Pharmingen or Bio-
legend). Anti-mouse VE-cadherin antibody was biotinylated in-
house using FluoReporter Mini-Biotin-XX Protein labeling kit
(Invitrogen). For depletion of differentiated hematopoietic cells
(Lineage, Lin), anti-mouse B220, CD3, and Ter119 antibodies con-
jugated with PerCP-Cy5.5 were used (eBioscience). Cell popula-Stem Celltionswere sorted using a FACSAria-II sorter (BD) followed by purity
checks. Gating of negative populations was performed on the basis
of fluorescence minus one (FMO) staining where one of the anti-
bodies was replaced with isotype control (IC) (BD Pharmingen).
Dead cells were excluded by 7AAD staining. For intracellular
staining, cells labeled with antibodies to surface antigens were
incubated with 0.5 mg/mL ethidium monoazide bromide (EMA)
solution (Sigma-Aldrich) to exclude dead cells. The cells were
then washed twice and fixed and stained with BD Cytofix/Cyto-
perm Kit and anti-RUNX1 rabbit monoclonal antibody (clone
EPR3099, Epitomics) followed by anti-rabbit Alexa Fluor 488 stain-
ing. Rabbit isotype control was used as FMO control. Data acquisi-
tion and data analysis were performed by Fortessa (BD) using
FlowJo software (Tree Star).
Confocal Microscopy
Whole-mount immunostaining was performed as previously
described (Yokomizo et al., 2012), with slight modifications. Em-
bryos dissected from the yolk sac and amnion were fixed with
cold acetone and, following dehydration by increasing concentra-
tions of methanol, the head, limbs, and one body wall were
removed. After rehydration in 50% methanol, washing with PBS
and blocking in 50% fetal calf serum/0.5% Triton X-100, the sam-
ples were incubated overnight with antibodies. For staining with
antibodies from the same species, incubations were performed
sequentially. Primary antibodies used were unconjugated goat
anti-mouse CD43 (cloneM19, Santa Cruz), rat anti-mouse VE-cad-
herin (clone 11D4.1, BD Pharmingen), rat anti-mouseCD45 (clone
30-F11, BD Pharmingen), rabbit anti-mouse RUNX1 (clone
EPR3099, Abcam), and these were detected by the secondary anti-
bodies anti-goat NL557 (R&D), anti-rat Alexa Fluor 647 (Invitro-
gen), or anti-rat Alexa 488 (Invitrogen) and anti-rabbit Alexa Fluor
647 (Abcam). After washing, the embryos were dehydrated with
methanol and cleared with BABB (one part benzyl alcohol, two
parts benzyl benzoate) solution (Yokomizo and Dzierzak, 2010).
Images were acquired with an inverted confocal microscope (Leica
SP8) and processed using Volocity software.
Statistics
Data on histograms presented as average ± SD and difference eval-
uated using t test. Numbers of pro-HSCs or HSCs were validated by
single-hit Poisson model using ELDA software (Hu and Smyth,
2009).
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